Edward Gane

57.6k citations
456 papers · 21.9k · 13 hit papers · h-index 70

Impact in

  • Hepatology top 0.01%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 0.01%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 265
    • Liver Disease and Transplantation 40
    • Hepatocellular Carcinoma Treatment and Prognosis 16
    • Hepatitis B Virus Studies 190
    • Liver Disease Diagnosis and Treatment 125

Edward Gane

445 papers receiving 21.4k citations

Edward Gane's Hit Papers

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study 2025 · 32 citations
320+10+20Years since publication4008001.2k

Peers

Edward Gane
Comparison fields: 5 of 133
  • Hepatology 14.6k
  • Epidemiology 14.7k
  • Transplantation 404
  • Infectious Diseases 1.8k
  • Immunology 831
Replace Stanislas Pol with:
Stanislas Pol France
Robert G. Gish United States
Geoffrey Dusheiko United Kingdom
Mitchell L. Shiffman United States
George Papatheodoridis Greece
Eric Lawitz United States
Ira M. Jacobson United States
Mark Sulkowski United States
Rafael Esteban Spain
Myron J. Tong United States
Edward Gane relative to Stanislas Pol France Stanislas Pol's profile →
Citations per field
00.5×2.6×
Stanislas Pol · 1×
Citations per year

Countries citing papers authored by Edward Gane

Since Specialization
Citations

This map shows the geographic impact of Edward Gane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Gane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Gane more than expected).

Fields of papers citing papers by Edward Gane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Gane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Gane. The network helps show where Edward Gane may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward Gane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Gane Line = papers co-authored together Edward Gane links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 456 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Hit paper breakdown →
20121288
2
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Hit paper breakdown →
20051144
3
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Hit paper breakdown →
2000953
4
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Hit paper breakdown →
1996793
5
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Hit paper breakdown →
2008741
6
Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B
Hit paper breakdown →
2007577
7
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Hit paper breakdown →
2013542
8 2008430
9 1997387
10 2005361
11 2010356
12
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Hit paper breakdown →
2020356
13 2010312
14 2017271
15 2014255
16 2010240
17
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study
Hit paper breakdown →
2019233
18 2008231
19 2007213
20 2007208

About Edward Gane

Edward Gane is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Immunology and Rheumatology, having authored 456 papers that have together received 21.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (265 papers), Hepatitis B Virus Studies (190 papers), Liver Disease Diagnosis and Treatment (125 papers), HIV/AIDS drug development and treatment (44 papers), Liver Disease and Transplantation (40 papers), Systemic Lupus Erythematosus Research (28 papers), Organ Transplantation Techniques and Outcomes (17 papers) and Hepatocellular Carcinoma Treatment and Prognosis (16 papers). The work is most often cited by research in Hepatology (14.6k citations), Epidemiology (14.7k citations), Transplantation (404 citations), Infectious Diseases (1.8k citations) and Immunology (831 citations). Edward Gane has collaborated with scholars based in New Zealand, United States and United Kingdom. Frequent co-authors include John G. McHutchison, Patrick Marcellin, George Lau, Yun‐Fan Liaw, Jia‐Horng Kao, G. Mani Subramanian, Teerha Piratvisuth, Nikolai V. Naoumov, Stefan Zeuzem and E. Jenny Heathcote. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Journal of Viral Hepatitis and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact